Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hormonal and surgical treatment in trans-women with BRCA1 mutations: a controversial topic.

The journal of sexual medicine - 1 Oct 2014

Colebunders Britt, T'Sjoen Guy, Weyers Steven, Monstrey Stan

Abstract excerpt

INTRODUCTION: Male-to-female transgender persons (trans-women) receive livelong cross-sex hormonal treatment in order to induce and maintain secondary female characteristics. One of the concerns of long-term estrogen treatment is the induction of carcinomas of estrogen-sensitive tissues such as the breast. BRCA1 mutations have been shown to account for a large proportion of inherited predispositions to breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to Breast Neoplasms
Share to BRCA1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Mammaplasty

Share to Mutation

Source

Identifiers

PMID: 25042481
DOI: 10.1111/jsm.12628

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hormonal and surgical treatment in trans-women with BRCA1 mutations: a controversial topic.PMID 25042481Read ↗

Difficulties of gender affirming treatment in trans women with BRCA1+ mutation: A case report.Semantic proximity Read ↗

Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation.Semantic proximity Read ↗

Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults.Semantic proximity Read ↗

Cancer prevention and screening in a BRCA2-positive male to female transgender patient.Semantic proximity Read ↗

Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation.Semantic proximity Read ↗

The role of estrogens in BRCA1/2 mutation carriers: reflections on the past, issues for the future.Semantic proximity Read ↗

The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows.Semantic proximity Read ↗

Cancer genetic counselors' experiences with transgender patients: A qualitative studySemantic proximity Read ↗

Transsexualism Ethiology and Medical Management: Between Scientific Evidence and Personal ExperiencesSemantic proximity Read ↗

BRCA1, hormone, and tissue-specific tumor suppression.Semantic proximity Read ↗

Hormonal prevention of hereditary breast cancer.Semantic proximity Read ↗

Exogenous reproductive hormone use in breast cancer survivors and previvors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.